Page 4 - EASL POSTGRADUATE COURSE

CONTENTS

6 EASL GOVERNING BOARD
7 WELCOME MESSAGE
9 PROGRAMME
12 POSTGRADUATE COURSE FACULTY
14 GLOSSARY
SESSION PAPERS

CHALLENGES IN THE DIAGNOSIS OF NASH
16 WHO SHOULD BE SCREENED FOR NASH?
Naga Chalasani, The United States
19 HISTOLOGICAL CLASSIFICATIONS IN NAFLD:
HOW AND WHEN TO TRUST THE PATHOLOGIST?
Pierre Bedossa, France
24 NON-INVASIVE DIAGNOSIS OF FIBROSIS IN NAFLD:
HOW RELIABLE IS IT?
Leon A. Adams, Australia
31 PEDIATRIC NASH: IS IT DIFFERENT AND SHOULD WE LOOK FOR IT?
Valerio Nobili, Italy
36 NASH IN LEAN PATIENTS
Vincent Wong, China

NAFLD AND INTERACTIONS WITH INSULIN RESISTANCE
41 EXCESSIVE BODY WEIGHT AND RISK OF NASH:
ARE ALL OBESE PATIENTS EQUAL?
Amalia Gastaldelli, Italy
46 INSULIN RESISTANCE:
SHOULD WE MEASURE IT AND DOES IT PROMOTE LIVER DISEASE PROGRESSION?
Elisabetta Bugianesi, Italy
50 DYSMETABOLIC HYPERFERRITINEMIA
Yves Deugnier*, Edouard Bardou-Jacquet, Carolie Jézéquel and Fabrice Lainé, France
53 BARIATRIC SURGERY: A CURE FOR NASH?
Carel le Roux, Ireland

4 Postgraduate Course Syllabus • Metabolic Liver Disease